DISCOVERIES REPORTS (ISSN 2393249X), 2020, volume 3

CITATION: 

Saha O, Rakhi NN, Sultana A, Rahman MM, Rahaman MM. SARS-CoV-2 and COVID-19: A Threat to Global Health. Discoveries Reports, 2020; 3: e13. DOI: 10.15190/drep.2020.7

Submitted: Oct. 18, 2020; Revised: Nov. 24, 2020; Accepted: Nov. 24, 2020; Published: Dec. 31, 2020;

 GO BACK to 2020, VOLUME 3

 GO BACK to DISCOVERIES REPORTS

SARS-CoV-2 and COVID-19: A Threat to Global Health

Otun Saha (1), Nadira Naznin Rakhi (2), Afroza Sultana (3), Md. Mahbubur Rahman (4), Md. Mizanur Rahaman (1,*)

(1) Department of Microbiology, University of Dhaka, Dhaka 1000, Bangladesh

(2) Department of Biotechnology and Genetic Engineering, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh

(3) Department of Microbiology, Noakhali Science and Technology University, Noakhali 3814, Bangladesh

(4) Department of Microbiology, Stamford University of Bangladesh, Dhaka, Bangladesh

*Correspondence to: Md. Mizanur Rahaman, Associate Professor, Department of Microbiology, University of Dhaka, Dhaka 1000; Email: razu002@du.ac.bd; Phone: +8801796585290.

Abstract

Since the outbreak of Coronavirus Disease 2019 (COVID-19) in China, in December 2019, scientists across the globe have been working relentlessly on the causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Unfortunately, despite the ongoing research at the genomic level, as well as the immunological and the pathological aspects of SARS-CoV-2, our knowledge about SARS-CoV-2 is still in the primary stage, even after one year from the beginning of the outbreak. As a result, the world is adopting a public awareness-based prevention and control strategy, together with significant efforts in developing and distributing several vaccines. Thus, this review summarizes the understandings of this pandemic, which will in turn be helpful in dealing with SARS-CoV-2 and provide a reference for future studies.

Access full text of the manuscript here: Full text (pdf)

References

1. Mim MA, Rakhi NN, Saha O, Rahaman MM.  Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria. Pathogens and Global Health, 2020; 114(4): 168-169.

2. Islam MM, Rakhi NN, Islam OK, Saha O, Rahaman MM. Challenges to be considered to evaluate the COVID-19 preparedness and outcome in Bangladesh. International Journal of Healthcare Management, 2020; 1-2.

3. www.DW.com. Coronavirus in India: Is public negligence causing surge in cases? https://www.dw.com/en/coronavirus-in-india-is-public-negligence-causing-surge-in-cases/a-54394810.2020.

4. Carfì A, Bernabei R, Landi F. Gemelli against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients after Acute COVID-19. JAMA, 2020; 324(6):603-605.

5. Wang H., Li X., Li T., Zhang S., Wang L., Wu X. et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases, 2020; 39:1629–1635.

6. Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proceedings of the National Academy of Sciences 2020; 117(17): 9241-9243.

7. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 2020; 395(10223): 497-506.

8. Kumar M, Taki K, Gahlot R, Sharma A, Dhangar K. A chronicle of SARS-CoV-2: Part-I-Epidemiology, diagnosis, prognosis, transmission and treatment. Science of The Total Environment, 2020, 139278.

9. Ramzy A, May T. Philippines Reports First Coronavirus Death Outside China. 2nd February 2020. Available at https://www.nytimes.com/ 2020/02/02/world/asia/philippines - coronavirus -china.html

10. Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current Biology, 2020; 30(7): 1346-51.

11. Yang N, Shen Y, Shi C, Ma AHY, Zhang X, Jian X et al. In-flight Transmission Cluster of COVID-19: A Retrospective Case Series. medRxiv 2020.

12. Reuters. Special Report: Italy and South Korea virus outbreaks reveal disparity in deaths and tactics. 2020. Available at: https://www.reuters.com/article/us-health-coronavirus-response-specialre-idUSKBN20Z27P.

13. Saha O, Rakhi NN, Towhid ST, Rahaman MM.  Reactivation of Severe Acute Respiratory Coronavirus-2 (SARS-CoV-2): Hoax or hurdle? International Journal of Healthcare Management, 2020; 13(3):265-66.

14. Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JIP et al. Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review. J of Clin Med 2020; 9(3): 623. 

15. Chu DK, Pan Y, Cheng S, Hui KP, Krishnan P, Liu Y et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chemistry, 2020; 66(4): 549-55.

16. Yee J, Unger L, Zadravecz F, Cariello P, Seibert A, Johnson MA et al. Novel coronavirus 2019 (COVID‐19): Emergence and implications for emergency care. J of the American College of Emergency Physicians Open, 2020; 1(2): 63-69.

17. Jing QL, Liu MJ, Yuan J, Zhang ZB, Zhang AR, Dean NE et al. Household Secondary Attack Rate of COVID-19 and Associated Determinants. medRxiv 2020.

18. Bi Q, Wu Y, Mei S et al. Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts. medRxiv 2020.

19. Lau JTF, Lau M, Kim JH et al. Probable Secondary Infections in Households of SARS Patients in Hong Kong. Emerg Infect Dis., 2004; 10: 235-243. 

20. Zhang L, Yang JR, Zhang Z, Lin Z. Genomic variations of SARS-CoV-2 suggest multiple outbreak sources of transmission. medRxiv 2020.

21. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 2020; 395(10223): 507-513.

22. Rahaman MM, Saha O, Rakhi NN, Chowdhury MMK, Sammonds P, Kamal AM. Overlapping of locust swarms with COVID-19 pandemic: a cascading disaster for Africa. Pathogens and Global Health 2020; 114(6):285-86.

23. Wu A, Peng Y, Huang B et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020; 27(3): 325-28.

24. Su Y, Anderson D, Young B, Zhu F, Linster M, Kalimuddin S et al. Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2. bioRxiv 2020.

25. Saha O, Hossain MS, Rahaman MM. Genomic exploration light on multiple origin with potential parsimony-informative sites of the severe acute respiratory syndrome coronavirus 2 in Bangladesh. Gene Reports, 2020; 21: 100951.

26. Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Reports, 2020; 19: 100682.

27. Dhama K, Sharun K, Tiwari R, Sircar S, Bhat S, Malik YS et al Coronavirus Disease 2019 – COVID-19. Preprints 2020, 2020030001.

28. Mathuria JP, Yadav R. Laboratory diagnosis of SARS-CoV-2-A review of current methods. Journal of Infection and Public Health, 2020; 13(7): 901-05.

29. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med., 2020; 382: 727-733.

30. Sahin AR., Erdogan A., Agaoglu PM., Dineri Y, Cakirci AY., Senel ME. et al. 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. EJMO 2020; 4(1): 1-7. doi: 10.14744/ejmo.2020.12220.

31. Shen M, Zhou Y, Ye J, AL-Maskri AAA, Kang Y, Zeng S et al.  Recent advances and perspectives of nucleic acid detection for coronavirus. J of Pharmaceutical Analysis 2020; 10(2): 97-101.

32. Hossain MS, Hami I, Sawrav MSS, Rabbi MF, Saha O, Bahadur NM, Rahaman MM. Drug Repurposing for Prevention and Treatment of COVID-19: A Clinical Landscape. Discoveries. 2020; 8(4): e121.

33. Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care, 2020; 8(1): 1-10.

34. Jarvis C. The Unusual Symptoms of COVID-19. The Scienties, 2020; Available at: https://www.the-scientist.com/news-opinion/the-unusual-symptoms-of-covid-19-67522

35. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis., 2020; 71(15): 762-68.

36. Wölfel R, Corman VM, Guggemos W. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581: 465-69.

37. Alberca RW, Pereira NZ, Oliveira LMDS, Gozzi-Silva SC, Sato MN. Pregnancy, viral infection, and COVID-19. Frontiers in Immunology, 2020; 11: 1662.

38. Ludvigsson JF.  Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica 2020; 109(6): 1088-1095.

39. Cai J, Xu J, Lin D et al.  A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020; 71(6):1547-51. 

40. Yan J, Guo J, Fan C, Juan J, Yu X et al.  Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases. American Journal of Obstetrics and Gynecology, 2020; 223(1): 111.e1-111.e4.

41. Ai T, Yang Z, Hou H et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology, 2020; 200642.

42. Cheng Y, Wong R, Soo YOY, Wong WS, Lee CK, Ng MHL et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. European J of Clin Microbiol and Infectious Dis. 2005; 24(1): 44-46.

43. US Food and Drug Administration. Coronavirus Treatment Acceleration Program (CTAP). https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap. 2020.

44. Sagonowsky E, Liu A, Blankenship K, Hale C, Kansteiner F. COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump. Fierce Pharma, 2020, Accessed at:  https://www.fiercepharma.com/pharma/coronavirus-tracker-novavax-boasts-billion-plus-shot-capacity-by-2021-russia-s-world-first.

45. Rosa S, Santos WC. Clinical trials on drug repositioning for COVID-19 treatment. Revista panamericana de salud publica = Pan American Journal of Public Health, 2020; 44: e40.

46. Wu R, Wang L, Kuo HCD, Shannar A, Peter R, Chou PJ et al. An Update on Current Therapeutic Drugs Treating COVID-19. Current Pharmacology Reports 2020, 6(1):56-70.

47. Zahid SH. Covid-19 vaccine: Hope and reality. The Financial Express, 2020. https://www.thefinancialexpress.com.bd/views/covid-19-vaccine-hope-and-reality-1589728682.2020.

48. Cherry JD, Krogstad P. SARS: The First Pandemic of the 21st Century. Pediatric research 2004; 56(1): 1-5.

49. Guzman J. Coronavirus patients are testing positive after recovery. The Hill, 2020; Available at: https://thehill.com/changing-america/well-being/prevention-cures/492489-more-coronavirus-patients-in-south-korea-are

50. The News. South Korean scientists conclude people cannot be infected twice with Covid-19. The News, 2020; Available at: https://tbsnews.net/coronavirus-chronicle/south-korean-scientists-conclude-people-cannot-be-infected-twice-covid-19

51. Ye G, Pan Z, Pan Y, Deng Q, Chen L et al.  Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. Journal of Infection, 2020; 80(5): e14-e17.